ArticleDiscover oncology2025

Low pre-treatment neutrophil-to-lymphocyte ratio predicted a better survival in recurrent/metastatic cervical cancer treated with PD-1/PD-L1 inhibitors.

Jing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.